Devin B. Tesar
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Immunology top 10%
- Biosimilars and Bioanalytical Methods
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 18
-
- Glycosylation and Glycoproteins Research 8
- Protein purification and stability 7
- Retinal Development and Disorders 3
- Viral Infectious Diseases and Gene Expression in Insects 2
- Co-authors
- Leslie A. Khawli (4 shared papers)C. Andrew Boswell (4 shared papers)Pamela J. Björkman (6 shared papers)Paul J. Fielder (2 shared papers)Frank‐Peter Theil (1 shared paper)Kiran Mukhyala (1 shared paper)Alavattam Sreedhara (4 shared papers)Paul A. Motchnik (1 shared paper)
- Journals
- mAbs (6 papers)Molecular Pharmaceutics (3 papers)Traffic (2 papers)Protein Engineering Design and Selection (2 papers)Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Devin B. Tesar
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Radiology, Nuclear Medicine and Imaging 898
- Immunology 293
- Molecular Biology 920
- Biotechnology 66
- Structural Biology 9
Countries citing papers authored by Devin B. Tesar
This map shows the geographic impact of Devin B. Tesar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin B. Tesar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin B. Tesar more than expected).
Fields of papers citing papers by Devin B. Tesar
This network shows the impact of papers produced by Devin B. Tesar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin B. Tesar. The network helps show where Devin B. Tesar may publish in the future.
Co-authors
The 25 scholars most cited alongside Devin B. Tesar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 340 | |
| 2 | 2010 | 317 | |
| 3 | 2014 | 99 | |
| 4 | 2006 | 75 | |
| 5 | 2014 | 67 | |
| 6 | 2015 | 63 | |
| 7 | 2011 | 63 | |
| 8 | 2008 | 49 | |
| 9 | 2019 | 47 | |
| 10 | 2023 | 39 | |
| 11 | 2010 | 26 | |
| 12 | 2010 | 25 | |
| 13 | 2007 | 24 | |
| 14 | 2022 | 14 | |
| 15 | 2017 | 13 | |
| 16 | 2013 | 11 | |
| 17 | 2019 | 8 | |
| 18 | 2015 | 4 | |
| 19 | 2024 | 4 | |
| 20 | 2024 | 4 |
About Devin B. Tesar
Devin B. Tesar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Ophthalmology and Oncology, having authored 24 papers that have together received 1.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (18 papers), Glycosylation and Glycoproteins Research (8 papers), Protein purification and stability (7 papers), Complement system in diseases (4 papers), Retinal Diseases and Treatments (4 papers), Retinal Development and Disorders (3 papers), Diabetes and associated disorders (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (898 citations), Immunology (293 citations), Molecular Biology (920 citations), Biotechnology (66 citations) and Structural Biology (9 citations). Devin B. Tesar has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Leslie A. Khawli, C. Andrew Boswell, Pamela J. Björkman, Paul J. Fielder, Frank‐Peter Theil, Kiran Mukhyala, Alavattam Sreedhara, Paul A. Motchnik, Yung‐Hsiang Kao and Tony Cano. Their work appears in journals such as mAbs, Molecular Pharmaceutics, Traffic, Protein Engineering Design and Selection and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.